GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gossamer Bio Inc (STU:4GB) » Definitions » Marketable Securities

Gossamer Bio (STU:4GB) Marketable Securities : €269.01 Mil (As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Gossamer Bio Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Gossamer Bio's Marketable Securities for the quarter that ended in Sep. 2024 was €269.01 Mil.

Gossamer Bio's annual Marketable Securities increased from Dec. 2021 (€125.51 Mil) to Dec. 2022 (€135.66 Mil) and increased from Dec. 2022 (€135.66 Mil) to Dec. 2023 (€242.38 Mil).

Gossamer Bio Marketable Securities Historical Data

The historical data trend for Gossamer Bio's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gossamer Bio Marketable Securities Chart

Gossamer Bio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Marketable Securities
Get a 7-Day Free Trial 240.07 21.84 125.51 135.66 242.38

Gossamer Bio Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 230.76 242.38 189.09 248.61 269.01

Gossamer Bio Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Gossamer Bio  (STU:4GB) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Gossamer Bio Marketable Securities Related Terms

Thank you for viewing the detailed overview of Gossamer Bio's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Gossamer Bio Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gossamer Bio Inc (STU:4GB) » Definitions » Marketable Securities
Comparable Companies
ABSI TSVT DSGN CDT ACRV SEER CYT BTAI TRVI CDXS OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
GOSS:USA
Address
3013 Science Park Road, Suite 200, San Diego, CA, USA, 92121
Website
https://www.gossamerbio.com
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Gossamer Bio Headlines

No Headlines